| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Albion Enterprise VCT PLC: Total Voting Rights and Capital | ||
| Mi | Albion Technology & General VCT PLC - Ordinary Shares: Total Voting Rights and Capital | ||
| Mi | Albion Crown VCT PLC: Total Voting Rights and Capital | ||
| Mi | Total number of shares and voting rights in Zealand Pharma as of December 31, 2025 | ||
| Mi | Trifork Group AG: 62/2025·Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities | ||
| Mi | JPMorgan Asset Management (Canada) Inc.: JPMorgan Announces Final Cash Distributions for the JPMorgan ETFs | ||
| Mi | JPMorgan Asset Management (Canada) Inc. Exchange Traded Funds 2025 Final Annual Reinvested Capital Gain Distributions | ||
| Mi | First Commerce Bancorp, Inc. Announces Completion of $40.0 Million Subordinated Note Offering | ||
| Mi | EXEL Industries: Total number of voting rights and shares at 11.30.2025 | ||
| Mi | NextNRG, Inc.: NextNRG Announces Shareholder Rewards Program Featuring EzFill Fueling Token | ||
| Mi | Shell plc: Voting Rights and Capital | ||
| Mi | FibroBiologics, Inc.: FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis | ||
| Mi | HyOrc Corporation: HyOrc Completes Factory Acceptance Test of 500kw ORC Turbine for International Customer | ||
| Mi | Reeflex Solutions Inc. Granted Management Cease Trade Order and Provides Bi-Weekly Status Update | ||
| Mi | AS Infortar: Aktsiaselts Infortar own share acquisition transactions | ||
| Mi | Hydreight Technologies Inc.: Hydreight Technologies Enters the At-Home STI Testing Market With Exclusive Distribution and 50,000 Pre-Orders | ||
| Mi | Profusa, Inc.: Profusa Bolsters European Commercial Network with New French Distributor, MedSell | ||
| Mi | Abeona Therapeutics Inc.: Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Mi | HPQ Silicon Inc.: HPQ Silicon 2025 Marked by Strategic Focus, Technical Validation, and a Clear Path Toward Commercialization | ||
| Mi | Lassila & Tikanoja plc: Change of issuer of Lassila & Tikanoja's EUR 75 million sustainability-linked notes | ||
| Mi | Foresight Enterprise VCT plc.: Total Voting Rights | ||
| Mi | Foresight Ventures VCT plc: Total Voting Rights | ||
| Mi | Foresight VCT PLC: Total Voting Rights | ||
| Mi | Foresight Technology VCT PLC: Total Voting Rights | ||
| Mi | BioAtla, Inc.: BioAtla and GATC Health Announce a $40 Million Special Purpose Vehicle (SPV) Transaction to Advance Ozuriftamab Vedotin (Oz-V) into a Registrational Trial for 2L+ Oropharyngeal Squamous Cell Carcinoma (OPSCC) |